Mesoblast (MESO) Research & Development: 2014-2023
Historic Research & Development for Mesoblast (MESO) over the last 8 years, with Jun 2023 value amounting to $73.3 million.
- Mesoblast's Research & Development rose 20.99% to $73.3 million in Q2 2023 from the same period last year, while for Jun 2023 it was $52.8 million, marking a year-over-year increase of 60.96%. This contributed to the annual value of $34.8 million for FY2025, which is 12.36% down from last year.
- As of Q2 2023, Mesoblast's Research & Development stood at $73.3 million, which was up 1,137.53% from -$7.1 million recorded in Q1 2023.
- Mesoblast's 5-year Research & Development high stood at $99.0 million for Q2 2021, and its period low was -$14.4 million during Q1 2019.
- For the 3-year period, Mesoblast's Research & Development averaged around $17.2 million, with its median value being -$7.4 million (2022).
- In the last 5 years, Mesoblast's Research & Development surged by 585.91% in 2020 and then tumbled by 115.50% in 2021.
- Quarterly analysis of 5 years shows Mesoblast's Research & Development stood at -$14.2 million in 2019, then declined by 0.59% to -$14.2 million in 2020, then grew by 28.37% to -$10.2 million in 2021, then grew by 24.66% to -$7.7 million in 2022, then rose by 20.99% to $73.3 million in 2023.
- Its Research & Development stands at $73.3 million for Q2 2023, versus -$7.1 million for Q1 2023 and -$7.7 million for Q4 2022.